– Seventh approved indication for RINVOQ in the European Union (EU) and the first and only oral Janus Kinase (JAK) inhibitor approved to treat adult patients with moderately to severely active Crohn’s disease – Third gastroenterology indication approved across AbbVie’s Inflammatory Bowel…

Did you lose money on investments in Dutch Bros? If so, please visit Dutch Bros Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. NEW YORK, April 17, 2023 /PRNewswire/ — Bernstein Liebhard LLP, a nationally…

Did you lose money on investments in Stanley Black & Decker? If so, please visit Stanley Black & Decker, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. NEW YORK, April 17, 2023 /PRNewswire/ — Bernstein…

Did you lose money on investments in Dish? If so, please visit DISH Network Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. NEW YORK, April 17, 2023 /PRNewswire/ — Bernstein Liebhard LLP, a…

Did you lose money on investments in Medical Properties Trust? If so, please visit Medical Properties Trust, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. NEW YORK, April 17, 2023 /PRNewswire/ — Bernstein…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.